vs
COMPASS MINERALS INTERNATIONAL INC（CMP）与IONIS PHARMACEUTICALS INC（IONS）财务数据对比。点击上方公司名可切换其他公司
COMPASS MINERALS INTERNATIONAL INC的季度营收约是IONIS PHARMACEUTICALS INC的1.9倍（$396.1M vs $203.3M），COMPASS MINERALS INTERNATIONAL INC净利率更高（4.7% vs -112.8%，领先117.5%），COMPASS MINERALS INTERNATIONAL INC同比增速更快（28.9% vs -10.3%），COMPASS MINERALS INTERNATIONAL INC自由现金流更多（$-59.8M vs $-159.0M），过去两年IONIS PHARMACEUTICALS INC的营收复合增速更高（30.4% vs 4.3%）
指南针矿产国际是一家美国上市矿产企业，总部位于堪萨斯州欧弗兰帕克，是盐、氯化镁和硫酸钾等产品的领先生产商。公司面向北美和英国客户供应经处理与未经处理的散装道路除冰盐，同时向全球种植者提供植物营养产品，此外也生产民用除冰、水质调节产品及相关商用产品。
IONIS制药是1989年成立的生物科技企业，总部位于美国加利福尼亚州卡尔斯巴德，专注于反义疗法、RNA干扰及CRISPR疗法的研发，2015年12月前曾以Isis制药的名称运营。
CMP vs IONS — 直观对比
营收规模更大
CMP
是对方的1.9倍
$203.3M
营收增速更快
CMP
高出39.2%
-10.3%
净利率更高
CMP
高出117.5%
-112.8%
自由现金流更多
CMP
多$99.2M
$-159.0M
两年增速更快
IONS
近两年复合增速
4.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $396.1M | $203.3M |
| 净利润 | $18.6M | $-229.4M |
| 毛利率 | 16.0% | 96.1% |
| 营业利润率 | 9.2% | -105.5% |
| 净利率 | 4.7% | -112.8% |
| 营收同比 | 28.9% | -10.3% |
| 净利润同比 | 178.8% | -119.8% |
| 每股收益（稀释后） | $0.43 | $-1.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CMPIONS
| Q4 25 | $396.1M | $203.3M | ||
| Q3 25 | $227.5M | $156.7M | ||
| Q2 25 | $214.6M | $452.0M | ||
| Q1 25 | $494.6M | $131.6M | ||
| Q4 24 | $307.2M | $226.6M | ||
| Q3 24 | $208.8M | $133.8M | ||
| Q2 24 | $202.9M | $225.3M | ||
| Q1 24 | $364.0M | $119.5M |
净利润CMPIONS
| Q4 25 | $18.6M | $-229.4M | ||
| Q3 25 | $-7.2M | $-128.6M | ||
| Q2 25 | $-17.0M | $123.6M | ||
| Q1 25 | $-32.0M | $-146.9M | ||
| Q4 24 | $-23.6M | $-104.3M | ||
| Q3 24 | $-48.3M | $-140.5M | ||
| Q2 24 | $-43.6M | $-66.3M | ||
| Q1 24 | $-38.9M | $-142.8M |
毛利率CMPIONS
| Q4 25 | 16.0% | 96.1% | ||
| Q3 25 | 16.9% | 98.5% | ||
| Q2 25 | 19.2% | 99.1% | ||
| Q1 25 | 15.5% | 98.9% | ||
| Q4 24 | 11.2% | 98.3% | ||
| Q3 24 | 9.3% | 99.2% | ||
| Q2 24 | 16.1% | 98.2% | ||
| Q1 24 | 19.7% | 98.2% |
营业利润率CMPIONS
| Q4 25 | 9.2% | -105.5% | ||
| Q3 25 | 5.3% | -102.2% | ||
| Q2 25 | 7.4% | 30.9% | ||
| Q1 25 | -0.6% | -111.6% | ||
| Q4 24 | 0.2% | -48.9% | ||
| Q3 24 | -14.3% | -111.1% | ||
| Q2 24 | 2.9% | -29.3% | ||
| Q1 24 | -10.8% | -125.1% |
净利率CMPIONS
| Q4 25 | 4.7% | -112.8% | ||
| Q3 25 | -3.2% | -82.1% | ||
| Q2 25 | -7.9% | 27.3% | ||
| Q1 25 | -6.5% | -111.6% | ||
| Q4 24 | -7.7% | -46.1% | ||
| Q3 24 | -23.1% | -105.0% | ||
| Q2 24 | -21.5% | -29.4% | ||
| Q1 24 | -10.7% | -119.5% |
每股收益（稀释后）CMPIONS
| Q4 25 | $0.43 | $-1.35 | ||
| Q3 25 | — | $-0.80 | ||
| Q2 25 | $-0.41 | $0.70 | ||
| Q1 25 | $-0.77 | $-0.93 | ||
| Q4 24 | $-0.57 | $-0.66 | ||
| Q3 24 | $-1.17 | $-0.95 | ||
| Q2 24 | $-1.05 | $-0.45 | ||
| Q1 24 | $-0.94 | $-0.98 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $46.7M | $2.7B |
| 总债务越低越好 | $890.0M | $1.8B |
| 股东权益账面价值 | $260.5M | $489.1M |
| 总资产 | $1.5B | $3.5B |
| 负债/权益比越低杠杆越低 | 3.42× | 3.71× |
8季度趋势，按日历期对齐
现金及短期投资CMPIONS
| Q4 25 | $46.7M | $2.7B | ||
| Q3 25 | $59.7M | $2.2B | ||
| Q2 25 | $79.4M | $2.3B | ||
| Q1 25 | $49.5M | $2.1B | ||
| Q4 24 | $45.8M | $2.3B | ||
| Q3 24 | $20.2M | $2.5B | ||
| Q2 24 | $12.8M | $2.1B | ||
| Q1 24 | $38.3M | $2.2B |
总债务CMPIONS
| Q4 25 | $890.0M | $1.8B | ||
| Q3 25 | $839.8M | — | ||
| Q2 25 | $833.4M | — | ||
| Q1 25 | $807.6M | — | ||
| Q4 24 | $974.4M | $1.3B | ||
| Q3 24 | $921.2M | — | ||
| Q2 24 | $875.1M | — | ||
| Q1 24 | $877.2M | — |
股东权益CMPIONS
| Q4 25 | $260.5M | $489.1M | ||
| Q3 25 | $234.1M | $618.0M | ||
| Q2 25 | $249.8M | $631.7M | ||
| Q1 25 | $236.5M | $475.7M | ||
| Q4 24 | $263.0M | $588.4M | ||
| Q3 24 | $316.6M | $662.5M | ||
| Q2 24 | $352.1M | $263.7M | ||
| Q1 24 | $400.4M | $296.5M |
总资产CMPIONS
| Q4 25 | $1.5B | $3.5B | ||
| Q3 25 | $1.5B | $3.0B | ||
| Q2 25 | $1.5B | $3.0B | ||
| Q1 25 | $1.5B | $2.8B | ||
| Q4 24 | $1.7B | $3.0B | ||
| Q3 24 | $1.6B | $3.1B | ||
| Q2 24 | $1.6B | $2.7B | ||
| Q1 24 | $1.7B | $2.8B |
负债/权益比CMPIONS
| Q4 25 | 3.42× | 3.71× | ||
| Q3 25 | 3.59× | — | ||
| Q2 25 | 3.34× | — | ||
| Q1 25 | 3.41× | — | ||
| Q4 24 | 3.70× | 2.13× | ||
| Q3 24 | 2.91× | — | ||
| Q2 24 | 2.49× | — | ||
| Q1 24 | 2.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.0M | $-137.7M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $-159.0M |
| 自由现金流率自由现金流/营收 | -15.1% | -78.2% |
| 资本支出强度资本支出/营收 | 5.8% | 10.5% |
| 现金转化率经营现金流/净利润 | -1.99× | — |
| 过去12个月自由现金流最近4个季度 | $94.1M | $-320.0M |
8季度趋势，按日历期对齐
经营现金流CMPIONS
| Q4 25 | $-37.0M | $-137.7M | ||
| Q3 25 | $-6.9M | $-131.4M | ||
| Q2 25 | $21.8M | $151.3M | ||
| Q1 25 | $186.9M | $-150.8M | ||
| Q4 24 | $-4.1M | $-116.1M | ||
| Q3 24 | $-12.7M | $-115.0M | ||
| Q2 24 | $-6.8M | $-119.9M | ||
| Q1 24 | $86.2M | $-149.9M |
自由现金流CMPIONS
| Q4 25 | $-59.8M | $-159.0M | ||
| Q3 25 | $-22.8M | $-136.7M | ||
| Q2 25 | $3.8M | $139.0M | ||
| Q1 25 | $172.9M | $-163.4M | ||
| Q4 24 | $-25.9M | $-141.6M | ||
| Q3 24 | $-33.6M | $-124.0M | ||
| Q2 24 | $-21.5M | $-126.1M | ||
| Q1 24 | $56.2M | $-154.4M |
自由现金流率CMPIONS
| Q4 25 | -15.1% | -78.2% | ||
| Q3 25 | -10.0% | -87.2% | ||
| Q2 25 | 1.8% | 30.8% | ||
| Q1 25 | 35.0% | -124.1% | ||
| Q4 24 | -8.4% | -62.5% | ||
| Q3 24 | -16.1% | -92.7% | ||
| Q2 24 | -10.6% | -56.0% | ||
| Q1 24 | 15.4% | -129.2% |
资本支出强度CMPIONS
| Q4 25 | 5.8% | 10.5% | ||
| Q3 25 | 7.0% | 3.4% | ||
| Q2 25 | 8.4% | 2.7% | ||
| Q1 25 | 2.8% | 9.6% | ||
| Q4 24 | 7.1% | 11.3% | ||
| Q3 24 | 10.0% | 6.8% | ||
| Q2 24 | 7.2% | 2.8% | ||
| Q1 24 | 8.2% | 3.8% |
现金转化率CMPIONS
| Q4 25 | -1.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMP
| Highway Deicing Salt | $210.8M | 53% |
| Consumer Industrial Salt | $120.7M | 30% |
| Plant Nutrition | $60.8M | 15% |
| Transferred Over Time | $2.8M | 1% |
| Other | $1.0M | 0% |
IONS
| Products | $58.0M | 29% |
| Spinraza Royalties | $54.0M | 27% |
| Collaborative Agreement Revenue | $52.4M | 26% |
| Wainus Royalties | $16.0M | 8% |
| Wainua Joint Development Revenue | $9.6M | 5% |
| Other Commercial | $7.6M | 4% |
| Other Royalties | $5.7M | 3% |
